ILMN
ILLUMINA, INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$226.10
−5.08%Forward multiples
Based on analyst estimates
- P/E forward
- 37.93x
- P/E 2026E
- 41.68x
- P/E 2027E
- 36.63x
- P/E 2028E
- 31.82x
- P/S forward
- 7.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- 38.39x
- PEG TTM
- 31.60x
- Price / book
- 10.87x
- Price / sales
- 7.53x
- Price / cash flow
- 27.79x
Enterprise value
- Enterprise value
- $35.2B
- EV / sales
- 7.75x
- EV / EBITDA
- 25.37x
- EV / EBIT
- 34.61x
- Market cap
- $34.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026